慢性腎臓病治療の世界市場規模調査＆予測、治療別、エンドユーザー別、地域別分析、2023-2030年

世界の慢性腎臓病治療市場は、2022年に約320億米ドルと評価され、予測期間2023-2030年には4%以上の健全な成長率で成長すると予測されています。

長期的な疾患は慢性腎臓病（CKD）として知られ、腎機能の進行性低下を特徴とします。腎臓は、血流から老廃物、余分な水分、毒素を除去するために不可欠です。腎臓はまた、血圧、電解質バランス、赤血球の生成をコントロールする働きもあります。CKDは通常、徐々に始まり、腎機能の程度に応じて軽度から重度まで様々な段階を経て進行します。CKDの最も一般的な原因には、様々な腎臓の病気や異常、糖尿病、高血圧などがあります。その結果、「慢性腎臓病（CKD）治療」には、腎臓障害の進行やそれに伴う影響を管理・予防するために考案された、さまざまな医療介入や技術が含まれます。慢性腎臓病治療市場は、慢性腎臓病の罹患率の増加や老人人口の増加などの要因により拡大しています。

米国疾病予防管理センター（CDC）の報告によると、2021年には3,700万人のアメリカ人、つまり7人に1人以上が慢性腎臓病に罹患しています。同様に、2022年7月にインド政府の国民健康ポータルサイトが発表した報告書によると、インドでは末期腎不全（ESRD）の有病率が上昇し、毎年約2.2万人と推定される新規患者数が大幅に増加しています。このように、世界中で腎臓の慢性疾患の有病率が上昇していることが、市場の成長を促進しています。高齢者人口の増加も慢性腎疾患治療市場を後押しする重要な要素です。CKDの発症や進行のリスクが高い高齢化社会と、最先端の治療法の人気の高まりは、市場の拡大をさらに促進すると予測されます。例えば、CDCの報告によると、慢性腎臓病患者の多くは65歳以上（38％）、次いで45歳から64歳（12％）、18歳から44歳（6％）です。グローブ銀行グループの推計によると、2020年の世界の高齢者数は7億2700万人であり、その後30年間で3倍に増え、2050年には15億人に達する可能性があります。このように、老年人口の増加が市場の成長に寄与しています。さらに、技術進歩の高まりと研究開発活動への投資の増加が、市場に有利な成長をもたらしています。しかし、慢性腎臓病治療の高額な費用と不十分なヘルスケアインフラが、2023-2030年の予測期間を通じて市場成長を阻害しています。

慢性腎臓病治療の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、疾病の増加、主要市場プレイヤーの台頭、治療手順技術の進歩などの要因により、2022年の市場を独占しました。一方、アジア太平洋地域は、様々な慢性疾患の増加、先進治療技術開拓のための提携・協力の増加、研究開発活動の活発化、市場における政府の積極的な参加などの要因により、最も速い速度で成長すると予測されています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 慢性腎臓病治療の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 慢性腎臓病治療の世界市場力学

• 慢性腎臓病治療市場の影響分析（2020-2030年）
  • 市場促進要因
    • 慢性腎臓病の罹患率の増加
    • 高齢者人口の増加
  • 市場の課題
    • 慢性腎臓病治療の高コスト
    • 不十分なヘルスケアインフラ
  • 市場機会
    • 技術進歩の高まり
    • 研究開発への投資の増加

第4章 慢性腎臓病治療の世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 慢性腎臓病治療の世界市場：治療別

• 市場スナップショット
• 慢性腎臓病治療の世界市場：治療別、実績 - ポテンシャル分析
• 慢性腎臓病治療の世界市場：治療別推定・予測、2020-2030年
• 慢性腎臓病治療市場、サブセグメント別分析
  • 薬剤
  • 透析療法

第6章 慢性腎臓病治療の世界市場：エンドユーザー別

• 市場スナップショット
• 慢性腎臓病治療の世界市場：エンドユーザー別、実績 - ポテンシャル分析
• 慢性腎臓病治療の世界市場：エンドユーザー別推定・予測、2020～2030年
• 慢性腎臓病治療市場のサブセグメント分析
  • 病院
  • 透析センター
  • その他

第7章 慢性腎臓病治療の世界市場：地域別分析

• 主要国
• 主な新興国
• 慢性腎臓病治療市場、地域別市場スナップショット
• 北米
  • 米国
    • 治療別の推定・予測、2020-2030年
    • エンドユーザー別の推定・予測、2020-2030年
  • カナダ
• 欧州慢性腎臓病治療市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋慢性腎臓病治療市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの慢性腎臓病治療市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第8章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • F. Hoffmann-La Roche Ltd
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Johnson & Johnson Pvt Ltd
  • Fresenius SE and Co. KGaA
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca plc
  • B. Braun SE
  • Pfizer Inc
  • Baxter International Inc
  • Becton, Dickinson and Company
  • AbbVie Inc.

第9章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Chronic Kidney Disease Treatment Market, report scope
• TABLE 2. Global Chronic Kidney Disease Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3. Global Chronic Kidney Disease Treatment Market estimates & forecasts by Treatment 2020-2030 (USD Billion)
• TABLE 4. Global Chronic Kidney Disease Treatment Market estimates & forecasts by End User 2020-2030 (USD Billion)
• TABLE 5. Global Chronic Kidney Disease Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 6. Global Chronic Kidney Disease Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7. Global Chronic Kidney Disease Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Chronic Kidney Disease Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Chronic Kidney Disease Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Chronic Kidney Disease Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Chronic Kidney Disease Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Chronic Kidney Disease Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Chronic Kidney Disease Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Chronic Kidney Disease Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. U.S. Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. U.S. Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 17. U.S. Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18. Canada Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 19. Canada Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 20. Canada Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21. UK Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 22. UK Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 23. UK Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24. Germany Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 25. Germany Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 26. Germany Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27. France Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 28. France Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 29. France Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30. Italy Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 31. Italy Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 32. Italy Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33. Spain Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 34. Spain Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 35. Spain Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36. RoE Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 37. RoE Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 38. RoE Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39. China Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 40. China Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 41. China Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42. India Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 43. India Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 44. India Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45. Japan Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 46. Japan Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 47. Japan Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48. South Korea Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 49. South Korea Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 50. South Korea Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51. Australia Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 52. Australia Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 53. Australia Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54. RoAPAC Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 55. RoAPAC Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57. Brazil Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 58. Brazil Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 59. Brazil Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60. Mexico Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 61. Mexico Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 62. Mexico Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63. RoLA Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 64. RoLA Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 65. RoLA Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66. Saudi Arabia Chronic Kidney Disease Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 67. South Africa Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 68. RoMEA Chronic Kidney Disease Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Chronic Kidney Disease Treatment Market
• TABLE 70. List of primary sources, used in the study of global Chronic Kidney Disease Treatment Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Chronic Kidney Disease Treatment Market, research methodology
• FIG 2. Global Chronic Kidney Disease Treatment Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Chronic Kidney Disease Treatment Market, key trends 2022
• FIG 5. Global Chronic Kidney Disease Treatment Market, growth prospects 2023-2030
• FIG 6. Global Chronic Kidney Disease Treatment Market, porters 5 force model
• FIG 7. Global Chronic Kidney Disease Treatment Market, pest analysis
• FIG 8. Global Chronic Kidney Disease Treatment Market, value chain analysis
• FIG 9. Global Chronic Kidney Disease Treatment Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Chronic Kidney Disease Treatment Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Chronic Kidney Disease Treatment Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Chronic Kidney Disease Treatment Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Chronic Kidney Disease Treatment Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Chronic Kidney Disease Treatment Market, regional snapshot 2020 & 2030
• FIG 15. North America Chronic Kidney Disease Treatment Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Chronic Kidney Disease Treatment Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Chronic Kidney Disease Treatment Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Chronic Kidney Disease Treatment Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Chronic Kidney Disease Treatment Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Chronic Kidney Disease Treatment Market is valued at approximately USD 32 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4% over the forecast period 2023-2030. A long-term disorder is known as chronic kidney disease (CKD); it is characterized by a progressive decline in kidney function. The kidneys are essential for removing waste materials, excess fluids, and toxins from the bloodstream. They also assist in controlling blood pressure, electrolyte balance, and the generation of red blood cells. CKD typically starts out gradually and progresses through a range of phases, from mild to severe, depending on the extent of renal function. The most common causes of CKD include various renal illnesses or abnormalities, diabetes, and hypertension. As a result, "chronic kidney disease (CKD) treatment" encompasses a range of medical interventions and techniques designed to manage and prevent the progression of kidney damage as well as the effects that are associated with it. The Chronic Kidney Disease Treatment market is expanding because of factors such as the increasing incidence of chronic kidney disease and the growing geriatric Population.

The Centres for Disease Control and Prevention (CDC) reported that 37 million Americans, or more than 1 in 7 persons, had chronic kidney disease in 2021. Similarly, as per a report by the national health portal of the Indian Government in July 2022, the prevalence of end-stage renal disease (ESRD) in India is leading to a significant rise in the number of new patients, estimated at approximately 2.2 lahks each year. Thus, the rising prevalence of kidney chronic disease across the globe is fostering the market growth. The increase in the elderly population is another important element boosting the chronic renal disease treatment market. The ageing population, which is at high risk for the onset and progression of CKD, and the rising popularity of cutting-edge treatments are predicted to further propel market expansion. For instance, the CDC reports that many patients with chronic kidney disease are 65 or older (38%), followed by those between the ages of 45 and 64 (12%), and those between the ages of 18 and 44 (6%). The Globe Bank Group estimates that there were 727 million elderly people in the globe in 2020, and that number may triple over the following three decades to reach 1.5 billion by the year 2050. Thus, the rising prevalence of geriatric population is catering the market growth. In addition, rising technological advancement and rising investment in research and development activities are creating lucrative growth in the market. However, the high cost of chronic kidney disease treatment and inadequate healthcare infrastructure stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Chronic Kidney Disease Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing factors such as rising prevelance of diseases, rising dominance of key market players, rising advancement in treatment procedure technology and more. Whereas, Asia Pacific is projected to growth at a fastest rate owing to factors such as rising prevelance of various chronic diseases, rising number of partnership and collaboration for development of advance treatment technologies, rising research and development activities and active participation of government in the market place.

Major market player included in this report are:

• F. Hoffmann-La Roche Ltd
• Johnson & Johnson Pvt Ltd
• Fresenius SE and Co. KGaA
• Teva Pharmaceutical Industries Ltd.
• AstraZeneca plc
• B. Braun SE
• Pfizer Inc
• Baxter International Inc
• Becton, Dickinson and Company
• AbbVie Inc.

Recent Developments in the Market:

• In February 2023, The European Union approved the use of Forxiga (dapagliflozin), a medication from AstraZeneca, to treat heart failure (HF) with reduced ejection fraction (HFrEF), as well as HF with mildly reduced and preserved ejection fraction (HFmrEF, HFpEF).
• In Aug 2022, Fresenius Medical Care, the leading provider of products and services for persons with renal illnesses worldwide, reports that the VersiPD Cycler System has received FDA approval. This next-generation portable automated peritoneal dialysis system is the smallest, lightest, and quietest dialysis cycler available in the United States.

Global Chronic Kidney Disease Treatment Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Treatment, End User, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:

• Drug
• Dialysis

By End User:

• Hospital
• Dialysis Center
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Chronic Kidney Disease Treatment Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Chronic Kidney Disease Treatment Market, by Treatment, 2020-2030 (USD Billion)
  • 1.2.3. Chronic Kidney Disease Treatment Market, by End User, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Chronic Kidney Disease Treatment Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Chronic Kidney Disease Treatment Market Dynamics

• 3.1. Chronic Kidney Disease Treatment Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of chronic kidney disease
    • 3.1.1.2. Growing Geriatric Population
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Chronic Kidney Disease Treatment
    • 3.1.2.2. Inadequate Healthcare Infrastructure
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising technological advancement
    • 3.1.3.2. Rising investment in research and development activities

Chapter 4. Global Chronic Kidney Disease Treatment Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Chronic Kidney Disease Treatment Market, by Treatment

• 5.1. Market Snapshot
• 5.2. Global Chronic Kidney Disease Treatment Market by Treatment, Performance - Potential Analysis
• 5.3. Global Chronic Kidney Disease Treatment Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
• 5.4. Chronic Kidney Disease Treatment Market, Sub Segment Analysis
  • 5.4.1. Drug
  • 5.4.2. Dialysis

Chapter 6. Global Chronic Kidney Disease Treatment Market, by End User

• 6.1. Market Snapshot
• 6.2. Global Chronic Kidney Disease Treatment Market by End User, Performance - Potential Analysis
• 6.3. Global Chronic Kidney Disease Treatment Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 6.4. Chronic Kidney Disease Treatment Market, Sub Segment Analysis
  • 6.4.1. Hospital
  • 6.4.2. Dialysis Center
  • 6.4.3. Others

Chapter 7. Global Chronic Kidney Disease Treatment Market, Regional Analysis

• 7.1. Top Leading Countries
• 7.2. Top Emerging Countries
• 7.3. Chronic Kidney Disease Treatment Market, Regional Market Snapshot
• 7.4. North America Chronic Kidney Disease Treatment Market
  • 7.4.1. U.S. Chronic Kidney Disease Treatment Market
    • 7.4.1.1. Treatment breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2. End User breakdown estimates & forecasts, 2020-2030
  • 7.4.2. Canada Chronic Kidney Disease Treatment Market
• 7.5. Europe Chronic Kidney Disease Treatment Market Snapshot
  • 7.5.1. U.K. Chronic Kidney Disease Treatment Market
  • 7.5.2. Germany Chronic Kidney Disease Treatment Market
  • 7.5.3. France Chronic Kidney Disease Treatment Market
  • 7.5.4. Spain Chronic Kidney Disease Treatment Market
  • 7.5.5. Italy Chronic Kidney Disease Treatment Market
  • 7.5.6. Rest of Europe Chronic Kidney Disease Treatment Market
• 7.6. Asia-Pacific Chronic Kidney Disease Treatment Market Snapshot
  • 7.6.1. China Chronic Kidney Disease Treatment Market
  • 7.6.2. India Chronic Kidney Disease Treatment Market
  • 7.6.3. Japan Chronic Kidney Disease Treatment Market
  • 7.6.4. Australia Chronic Kidney Disease Treatment Market
  • 7.6.5. South Korea Chronic Kidney Disease Treatment Market
  • 7.6.6. Rest of Asia Pacific Chronic Kidney Disease Treatment Market
• 7.7. Latin America Chronic Kidney Disease Treatment Market Snapshot
  • 7.7.1. Brazil Chronic Kidney Disease Treatment Market
  • 7.7.2. Mexico Chronic Kidney Disease Treatment Market
• 7.8. Middle East & Africa Chronic Kidney Disease Treatment Market
  • 7.8.1. Saudi Arabia Chronic Kidney Disease Treatment Market
  • 7.8.2. South Africa Chronic Kidney Disease Treatment Market
  • 7.8.3. Rest of Middle East & Africa Chronic Kidney Disease Treatment Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Company 1
  • 8.1.2. Company 2
  • 8.1.3. Company 3
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. F. Hoffmann-La Roche Ltd
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Recent Developments
  • 8.3.2. Johnson & Johnson Pvt Ltd
  • 8.3.3. Fresenius SE and Co. KGaA
  • 8.3.4. Teva Pharmaceutical Industries Ltd.
  • 8.3.5. AstraZeneca plc
  • 8.3.6. B. Braun SE
  • 8.3.7. Pfizer Inc
  • 8.3.8. Baxter International Inc
  • 8.3.9. Becton, Dickinson and Company
  • 8.3.10. AbbVie Inc.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption